HUTCHMED (China) (HCM) Other Accumulated Expenses (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Other Accumulated Expenses of $4.5 million for Q2 2026, down 12.47% year-over-year from $5.1 million in Q2 2025, and down 9.77% quarter-over-quarter from $5.0 million in Q4 2025.
HUTCHMED (China) (HCM) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Other Accumulated Expenses for 12 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Accumulated Expenses fell 12.47% year-over-year to $4.5 million; the TTM figure through Jun 2026 stood at $4.5 million (down 12.47% YoY), while the FY2025 annual figure was $5.0 million, down 60.21% from the prior year.
- Other Accumulated Expenses declined to $4.5 million in Q2 2026 per HCM's latest filing, from $5.0 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $37.2 million in Q2 2022 and bottomed at $4.5 million in Q2 2026.
- Historically, Other Accumulated Expenses has averaged $11.1 million across 5 years, with a median of $6.8 million in 2023.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 443.17% — and 2023, when it tumbled 81.71%.
- HUTCHMED (China)'s Other Accumulated Expenses stood at $12.2 million in 2022, then dropped by 14.2% to $10.5 million in 2023, then gained by 19.09% to $12.5 million in 2024, then plunged by 60.21% to $5.0 million in 2025, then decreased by 9.77% to $4.5 million in 2026.
- Business Quant data shows HCM's Other Accumulated Expenses at $4.5 million in Q2 2026, $5.0 million in Q4 2025, and $5.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Dec 31, 2024 | 12.48 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Dec 31, 2023 | 10.48 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Dec 31, 2022 | 12.21 Mn |
| Jun 30, 2022 | 37.25 Mn |
| Dec 31, 2021 | 17.19 Mn |
| Jun 30, 2021 | 6.86 Mn |
| Mar 31, 2021 | 5.58 Mn |
| Dec 31, 2020 | 4.38 Mn |
| Jun 30, 2020 | 3.93 Mn |
| Dec 31, 2019 | 5.86 Mn |
| Sep 30, 2019 | 4.07 Mn |
| Jun 30, 2019 | 5.36 Mn |
| Mar 31, 2019 | 3.21 Mn |
| Dec 31, 2018 | 26.61 Mn |
| Jun 30, 2018 | 31.16 Mn |